
|Articles|November 15, 2002
UVB Options
Excimer laser, fiber-optic modalities effective in less timePhysician: Henry W. Lim, M.D.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Lebrikizumab Earns FDA Approval for Less Frequent, Every-8-Week Maintenance Dosing in AD
5














